| MDFGX | VIGRX | MDFGX / VIGRX | |
| Total Expense Ratio | 0.92 | 0.17 | 541% |
| Annual Report Gross Expense Ratio | 0.97 | 0.17 | 571% |
| Fund Existence | 28 years | 33 years | - |
| Gain YTD | -4.539 | 20.611 | -22% |
| Front Load | 5% | N/A | - |
| Min. Initial Investment | 1000 | 3000 | 33% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 3.79B | 353B | 1% |
| Annual Yield % from dividends | 0.00 | 0.30 | - |
| Returns for 1 year | -7.90 | 16.34 | -48% |
| Returns for 3 years | 60.37 | 134.39 | 45% |
| Returns for 5 years | -2.65 | 97.14 | -3% |
| Returns for 10 years | 51.18 | 359.04 | 14% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MIOPX | 31.25 | 0.11 | +0.35% |
| Morgan Stanley Inst International Opp A | |||
| UBVAX | 76.17 | 0.17 | +0.22% |
| Undiscovered Managers Behavioral Val A | |||
| NBSLX | 56.39 | 0.01 | +0.02% |
| Neuberger Quality Equity I | |||
| TLORX | 8.92 | N/A | N/A |
| Transamerica Large Value Opps R | |||
| LYFCX | 15.64 | -0.10 | -0.64% |
| AlphaCentric Life Sciences & Hlthcare C | |||